ORBIMED ADVISORS LLC RAPT Therapeutics, Inc. Transaction History

ORBIMED ADVISORS LLC portfolio value:

$30.10M
portfolio value

ORBIMED ADVISORS LLC quarter portfolio value change:

+31.84%
quarter

RAPT Therapeutics, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Increase +44.40% 384.67K shares 14.28M $24.06 1.25M
Q2 2022 share Increase +139.80% 505.09K shares 7.86M $18.25 866.39K
Q1 2022 share Increase +66.50% 144.3K shares -25K $21.99 361.3K
Q4 2021 share Increase 0.00% 217K shares 7.97M $36.28 217K